Acute Respiratory Distress Syndrome(ARDS) in Neonates

计划入组 200 人 · 首次发布于 2017 年 7 月 24 日

Carperitide in Acute Respiratory Distress Syndrome (ARDS)

首次发布于 2002 年 2 月 1 日

Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial

计划入组 160 人 · 首次发布于 2025 年 8 月 14 日

Acute Respiratory Distress Syndrome therapy(ImStem Biotechnology, Inc)

immunological directed cellular therapy (oral, acute respiratory distress syndrome)

mesenchymal stem cell therapy (respiratory distress syndrome)

Edesa Biotech

Canada

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

InflaRx's GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial

BioAegis Therapeutics Initiates Phase 2 Trial of Gelsolin for Acute Respiratory Distress Syndrome

Healios KK's MultiStem Therapy Advances to Global Phase 3 Trial for ARDS